Moreover, VPS34-IN-1 treatment led to a decreased percentage of CD133 + (CSC surface marker) positive MHCC97H and Huh7 cells and resulted in smaller tumor sizes in a tumor xenograft model, indicating VPS34 inhibition attenuates cancer cell proliferation. This evidence concerns the gene PROM1 and neoplasm.